zofenopril has been researched along with Diabetes Mellitus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agabiti-Rosei, E; Manolis, A; Omboni, S; Zava, D | 1 |
Agabiti-Rosei, E; Borghi, C; Malacco, E; Manolis, A; Modesti, PA; Napoli, C; Omboni, S; Parati, G | 1 |
Ambrosioni, E; Bacchelli, S; Borghi, C; Esposti, DD | 1 |
1 review(s) available for zofenopril and Diabetes Mellitus
Article | Year |
---|---|
Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Biphenyl Compounds; Blood Glucose; Blood Pressure; C-Reactive Protein; Captopril; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Inflammation Mediators; Irbesartan; Lipids; Male; Middle Aged; Pulse Wave Analysis; Randomized Controlled Trials as Topic; Risk Factors; Tetrazoles; Vascular Stiffness | 2017 |
2 trial(s) available for zofenopril and Diabetes Mellitus
Article | Year |
---|---|
Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Biphenyl Compounds; Captopril; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles; Treatment Outcome; Young Adult | 2014 |
Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatine Kinase; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Smoking; Survival Analysis; Time Factors | 2003 |